BIOMOTCPharmaceutical PreparationsFiscal year ends December 31
BIOMOLECULAR LIFE HOLDINGS, INC.
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 19, 2015
$0.79−0.02 (-2.47%)
Close on Oct 19, 2026
- Market cap
- $67.51M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Biomolecular Life's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Haig Keledjian CEO, Director, 10% owner | Nov 1, 2007 | Other | −2,400,000 | $0.06 | $144.00K | 17,605,302 |
| Haig Keledjian CEO and President, Director, 10% owner | Mar 8, 2007 | Other | −808,213 | $0.08 | $64.66K | 19,714,317 |
| Haig Keledjian CEO and President, Director, 10% owner | Mar 8, 2007 | Other | −1,000,000 | $0.05 | $50.00K | 19,522,530 |
| Haig Keledjian CEO and President, Director, 10% owner | Mar 8, 2007 | Exercise | +482,772 | $0.40 | $193.11K | 21,005,302 |
| Hampar Karageozian Director, 10% owner | Dec 19, 2006 | Gift | −1,000,000 | – | – | 9,276,221 |
| Monica Denise Ord Sr. VP Comm. & Corp. Dev. | Sep 11, 2006 | Sale | +300,000 | $0.16 | $48.00K | 1,715,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.